Recent research has suggested that Ozempic, a medication primarily prescribed for managing Type 2 diabetes, may also play a significant role in reducing...
By 193cc Agency CouncilSeptember 26, 2024In a recent Senate testimony, Lars Jørgensen, the CEO of Novo Nordisk, defended the pricing of Ozempic, the company’s widely used medication for...
By 193cc Agency CouncilSeptember 24, 2024Recent research has shed new light on the weight loss effects of the diabetes and weight management medications Mounjaro and Zepbound. According to...
By 193cc Agency CouncilSeptember 12, 2024